About Us

Cell Sorting With Microbubbles

At Akadeum, we strive to disrupt the status quo user experience to improve your workflow.


Founded in 2014, Akadeum was established to fundamentally change the way that isolating cells and other biological targets is approached.

July 2012

Founders of Akadeum begin working together

January 2014

Akadeum team selected & attends Innovation Corp program through the National Science Foundation

Learn more

March 2014

Akadeum Life Sciences founded

June 2015

Akadeum establishes Ann Arbor development headquarters


Ongoing development of Buoyancy Activated Cell Sorting (BACS™) product line

View our Products

Our Team

Brandon McNaughton, PhD: Chief Executive Officer

As a tech entrepreneur and inventor, Brandon has devoted his career to adding value to early-stage technology development and startup companies, and brings deep startup and venture-capital experience to the team.


Before Akadeum, he served as entrepreneur in residence for Detroit Innovate, which is an early-stage venture fund facilitated by Invest Detroit. He also founded and served as chief technology officer of venture capital‐backed startup Life Magnetics.


Brandon is a recognized expert on customer discovery and teaches this at a cornerstone entrepreneurship course at the University of Michigan Center for Entrepreneurship.


John Younger, MD, MS: Chief Technology Officer

John is a nationally‐recognized physician scientist who, before co‐founding Akadeum, practiced emergency medicine and lead an NIH‐ and National Science Foundation‐funded research lab the University of Michigan.


In this context, he has extensively researched how bacteria and human cells interact with engineered materials, and is routinely called upon by federal agencies to evaluate science and technology proposals.


John left the University of Michigan in 2015 to join the leadership team of Akadeum full time.


John Dahler: Chief Financial Officer

John Dahler is a successful financial executive at both early stage startups and public corporations.

He has served as Chief Financial Officer at Accuri Cytometers (acquired by Becton Dickinson for $205 M), Ambion (acquired by Applied Biosystems for $273 M), and Promega (>$300 M revenue). John has extensive experience leading mergers and acquisitions in addition to business restructuring, venture led financing, strategic planning and operational management.

John received his Bachelor of Sciences degree from the University of Wisconsin and has served on several not-for-profit boards. John is certified as both a CPA and CMA.


Leo J. Ostruszka, PhD: Principal Scientist

Leo brings a strong knowledge of product development with a focus on cytometry-related technologies to the Akadeum team. His efforts have focused on understanding user needs, as well as integrating new technologies into user workflows to solve problems.


Prior to joining Akeadeum Life Sciences, Leo was a Staff Scientist at BD Biosciences where, among other projects, he led the software development and integration effort for the BD FACSVia Clinical Flow Cytometer. Leo joined BD as part of acquisition of Accuri Cytometers, Inc. in 2011. He was an early member of the Accuri team, joining in 2006, and was the lead scientist for the development, testing and launch of the Accuri C6 Flow Cytometer.


Leo received a Ph.D. in Pharmacology from the University of Michigan in 2001 and a B.S. in Chemistry from the University of Dayton in 1995.


Thomas Jones: Product and Sales Manager

Thomas is an experienced genetics researcher who also has experience in building customer relationships and generating sales.

He spent 5 years at the Unviersity of Michigan in the national-renowned Human Genetics Department. In this work, Thomas was a lab manager and commonly performed animal studies, tissue analysis, and genetic testing.

He obtained a BS in Cell and Molecular Biology at the University of Michigan.